Long-term beta-blockade: prolonged protective action on the ischaemic myocardium

Area of Science:

• Cardiovascular Pharmacology
• Myocardial Ischemia Research
• Beta-blocker Drug Effects

Background:

• Acute beta-blockade protects against myocardial ischemia.
• The long-term protective effects of beta-blockade, independent of acute action, require further investigation.
• The role of intrinsic sympathomimetic activity (ISA) in long-term beta-blockade's cardioprotection is not fully understood.

Purpose of the Study:

• To assess if long-term beta-blockade provides protection against myocardial ischemia separate from acute effects.
• To investigate the influence of intrinsic sympathomimetic activity (ISA) on this additional protection.
• To compare the effects of oxprenolol (with ISA) and propranolol (without ISA) on myocardial recovery after ischemia.

Main Methods:

• Rats were administered equipotent oral doses of oxprenolol (with ISA) or propranolol (without ISA) for 3 weeks.
• Isolated working heart preparations were used to assess cardiac function at various times post-drug administration.
• Hearts underwent 30 minutes of reduced flow ischemia followed by aerobic reperfusion to measure functional recovery.

Main Results:

• Chronically beta-blocked hearts showed improved basal function and increased cellular creatine phosphate and glycogen levels post-ischemia, even when drug levels were undetectable.
• Hearts from both oxprenolol and propranolol groups demonstrated enhanced functional recovery compared to controls.
• Oxprenolol-treated hearts exhibited superior heart rate recovery compared to propranolol and untreated groups.

Conclusions:

• Long-term beta-blockade confers beneficial secondary effects on the ischemic myocardium, particularly under high catecholamine conditions.
• The intrinsic sympathomimetic activity (ISA) present in oxprenolol offers advantages for post-ischemic functional recovery.
• These findings suggest that certain long-term beta-blocker therapies may improve myocardial resilience to ischemic events.